Novartis
NEWS
BridgeBio stepped in to take over the drug and also launch a subsidiary, QED Therapeutics, to drive the development of infigratinib.
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
During an international conference in Davos, Switzerland, President Donald Trump sat down with the leaders of several European life science companies to encourage more investment in the United States.
Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis.
Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year.
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires.
Life sciences professionals don’t have to look far for opportunity in Genetown.
Novartis has found its new chief of oncology.
2017 was the second-best year for FDA approvals since 1996.
JOBS
IN THE PRESS